Eli Lilly and Co (NYSE:LLY)

89.71
Delayed Data
As of Jul 13
 +0.80 / +0.90%
Today’s Change
73.69
Today|||52-Week Range
89.87
+6.22%
Year-to-Date
Top Analyst Reports for PepsiCo, Eli Lilly & Broadcom
Jul 13 / Zacks.com - Paid Partner Content
Is Pfizer's Price Hike an Effect of Drug Policy on Sector?
Jul 03 / Zacks.com - Paid Partner Content
Pfizer to Defer Price Increases After Discussion With Trump
Jul 11 / Zacks.com - Paid Partner Content
Merck's Keytruda Gets Priority Review in Difficult Lung Cancer
Jul 03 / Zacks.com - Paid Partner Content
Biogen's Alzheimer Disease Candidate Succeeds in Phase II
Jul 06 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close88.91
Today’s open88.83
Day’s range88.54 - 89.87
Volume3,334,987
Average volume (3 months)3,784,578
Market cap$90.2B
Data as of 4:04pm ET, 07/13/2018

Growth & Valuation

Earnings growth (last year)-107.36%
Earnings growth (this year)+20.02%
Earnings growth (next 5 years)+11.10%
Revenue growth (last year)+7.77%
P/E ratio83.8
Price/Sales3.88
Price/Book7.88

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.32+0.51%
NVONovo Nordisk-0.02-0.04%
BMYBristol-Myers Squibb+0.05+0.09%
GSKGlaxoSmithKline-0.01-0.02%
Data as of 4:02pm ET, 07/13/2018

Financials

Next reporting dateJuly 24, 2018
EPS forecast (this quarter)$1.29
Annual revenue (last year)$22.9B
Annual profit (last year)-$204.1M
Net profit margin-0.89%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
David A. Ricks
Senior VP-Biotechnology &
Autoimmunity Research
Thomas F. Bumol
Corporate headquarters
Indianapolis, Indiana

Forecasts